About NewLimit
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $435,000,000 · Series-B+
x.com
- Capital Raise
Raised $45,000,000 · Series-B+
- Capital Raise
Raised $130,000,000 · Series-B+
blog.newlimit.com
- Capital Raise
Raised $40,000,000 · Series-A
- Milestone
X account created (@newlimit)
43.1K followers
- Milestone
Website domain registered
newlimit.com
Investors & Backers
Funding History
Founders & Leadership
Blake Byers
Co-founder
Brian Armstrong
Co-founder
Previously / Related: Bison Trails
Greg Johnson
Co-Founder & Head of Machine Learning
Jacob Kimmel
Co-founder & CEO
Press Coverage & Sources
x.com/newlimit/status/2061849237156159511
boost.vc/portfolio
startups.gallery/companies/newlimit
blog.newlimit.com/p/newlimit-has-raised-an-additional
blog.newlimit.com/p/newlimit-raises-130-million-series
techcrunch.com/2023/05/16/newlimit-cofounded-by-coinbase-ceo-brian-armstrong-raises-40m-to-extend-life/
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com